Literature DB >> 11850290

Characterization of a new extended-spectrum beta-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey.

Mariagrazia Perilli1, Bernardetta Segatore, Maria Rosaria De Massis, Nicola Franceschini, Ciro Bianchi, Gian Maria Rossolini, Gianfranco Amicosante.   

Abstract

A new natural TEM derivative, named TEM-87, was identified in a Proteus mirabilis isolate from an Italian hospital. Compared to TEM-1, TEM-87 contains the following mutations: E104K, R164C, and M182T. Kinetic analysis of TEM-87 revealed extended-spectrum activity against oxyimino cephalosporins (preferentially ceftazidime) and aztreonam. Expression of blaTEM-87 in Escherichia coli decreased the host susceptibility to these drugs.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11850290      PMCID： PMC127476          DOI： 10.1128/AAC.46.3.925-928.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

Review 1.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

Review 2.  beta-Lactamases: protein evolution in real time.

Authors:  J Petrosino; C Cantu; T Palzkill
Journal:  Trends Microbiol       Date:  1998-08       Impact factor: 17.079

3.  Direct sequencing of the amplified structural gene and promoter for the extended-broad-spectrum beta-lactamase TEM-9 (RHH-1) of Klebsiella pneumoniae.

Authors:  C Mabilat; S Goussard; W Sougakoff; R C Spencer; P Courvalin
Journal:  Plasmid       Date:  1990-01       Impact factor: 3.466

4.  Automated analysis of enzyme inactivation phenomena. Application to beta-lactamases and DD-peptidases.

Authors:  F De Meester; B Joris; G Reckinger; C Bellefroid-Bourguignon; J M Frère; S G Waley
Journal:  Biochem Pharmacol       Date:  1987-07-15       Impact factor: 5.858

5.  Diversity of TEM mutants in Proteus mirabilis.

Authors:  R Bonnet; C De Champs; D Sirot; C Chanal; R Labia; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

6.  Complete amino acid sequence of p453-plasmid-mediated PIT-2 beta-lactamase (SHV-1).

Authors:  M Barthélémy; J Peduzzi; R Labia
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

7.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

8.  Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322.

Authors:  J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

Review 9.  Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies.

Authors:  J Sirot; C Chanal; A Petit; D Sirot; R Labia; G Gerbaud
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

10.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553
View more
  9 in total

1.  Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey.

Authors:  Mariagrazia Perilli; Emanuela Dell'Amico; Bernardetta Segatore; Maria Rosaria de Massis; Ciro Bianchi; Francesco Luzzaro; Gian Maria Rossolini; Antonio Toniolo; Giuseppe Nicoletti; Gianfranco Amicosante
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Biochemical characterization of TEM-92 extended-spectrum beta-lactamase, a protein differing from TEM-52 in the signal peptide.

Authors:  Mariagrazia Perilli; Bernardetta Segatore; Maria Rosaria De Massis; Laura Pagani; Francesco Luzzaro; Gian Maria Rossolini; Gianfranco Amicosante
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

3.  A new TEM-derived extended-spectrum beta-lactamase (TEM-91) with an R164C substitution at the omega-loop confers ceftazidime resistance.

Authors:  Hiroshi Kurokawa; Naohiro Shibata; Yohei Doi; Keigo Shibayama; Kazunari Kamachi; Tetsuya Yagi; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

4.  Biochemical characterization of laboratory mutants of extended-spectrum beta-lactamase TEM-60.

Authors:  Bibiana Caporale; Nicola Franceschini; Mariagrazia Perilli; Bernardetta Segatore; Gian Maria Rossolini; Gianfranco Amicosante
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

5.  New TEM-derived extended-spectrum beta-lactamase and its genomic context in plasmids from Salmonella enterica serovar derby isolates from Uruguay.

Authors:  Rafael Vignoli; Nicolas F Cordeiro; Virginia García; María Inés Mota; Laura Betancor; Pablo Power; José A Chabalgoity; Felipe Schelotto; Gabriel Gutkind; Juan A Ayala
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

6.  TEM-187, a new extended-spectrum β-lactamase with weak activity in a Proteus mirabilis clinical strain.

Authors:  Stéphane Corvec; Racha Beyrouthy; Lise Crémet; Guillaume Ghislain Aubin; Frédéric Robin; Richard Bonnet; Alain Reynaud
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

7.  TEM-184, a Novel TEM-Derived Extended-Spectrum β-Lactamase with Enhanced Activity against Aztreonam.

Authors:  Alessandra Piccirilli; Mariagrazia Perilli; Gianfranco Amicosante; Viola Conte; Carlo Tascini; Gian Maria Rossolini; Tommaso Giani
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

8.  Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Barbara Fiori; Angela Raffaella Losito; Tiziana D'Inzeo; Lara Campana; Alberto Ruggeri; Eugenia Di Meco; Elvira Liberto; Giovanni Fadda; Roberto Cauda; Teresa Spanu
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

9.  An analysis of why highly similar enzymes evolve differently.

Authors:  Fahd K Majiduddin; Timothy Palzkill
Journal:  Genetics       Date:  2003-02       Impact factor: 4.562
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.